Harmony Biosciences Holdings, Inc. Common Stock Share Price
NASDAQ: HRMYHealthcare
Live Harmony Biosciences Holdings, Inc. Common Stock Share Price Chart
O H L
Harmony Biosciences Holdings, Inc. Common Stock Performance Overview
Days Range
▼
$42.60Low
$42.88High
Markets Today
| Previous Close | $42.74 |
|---|---|
| Open | $42.88 |
| Volume | 102,243 |
| Day's Range | $42.60 - $42.88 |
| 52W Range | $25.52 - $43.49 |
| Market Cap | $2.46 B |
Historical Performance
| 1M Returns | +10.07 |
|---|---|
| 3M Returns | +28.43 |
| 6M Returns | +53.46 |
| 1Y Returns | +30.98 |
| 5Y Returns | +16.17 |
| 10Y Returns | NA |
Harmony Biosciences Holdings, Inc. Common Stock Fundamentals
| Market Cap | $2.46 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 13.66 |
| PEG Ratio | N/A |
| Revenue | $868.45 M |
| ROE TTM | 0.21 |
| EPS TTM | $3.09 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.46 |
| EBITDA | $233.80 M |
| Profit Margin | 18.27 |
| Market Cap | $2.46 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 13.66 |
| PEG Ratio | N/A |
| Revenue | $868.45 M |
| ROE TTM | 0.21 |
| EPS TTM | $3.09 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.46 |
| EBITDA | $233.80 M |
| Profit Margin | 18.27 |
Harmony Biosciences Holdings, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $184.73 M | $200.49 M | $239.46 M | $243.78 M | $215.39 M | $261.28 M |
| Gross Profit + | $152.74 M | $162.34 M | $179.81 M | $175.23 M | $170.88 M | $198.08 M |
| Operating Income | $56.24 M | $48.18 M | $65.49 M | $38.56 M | $37.29 M | $89.32 M |
| EBITDA | $62.21 M | $42.23 M | $71.45 M | $45.99 M | $43.26 M | $83.36 M |
| Interest Expense | -$3.84 M | -$3.48 M | -$3.62 M | -$3.55 M | -$3.23 M | -$2.92 M |
| Depreciation | $5.97 M | -$5.96 M | $5.97 M | $7.43 M | $5.97 M | -$5.95 M |
| Income Before Tax | $57.18 M | $49.64 M | $67.49 M | $40.76 M | $39.69 M | $93.27 M |
| Income Tax Expense | $11.62 M | $9.86 M | $16.63 M | $18.27 M | $7.20 M | $17.83 M |
| Net Income + | $45.56 M | $39.78 M | $50.87 M | $22.49 M | $32.49 M | $75.43 M |
| Net Profit Margin | 24.66% | 19.84% | 21.24% | 9.22% | 15.08% | 28.87% |
Harmony Biosciences Holdings, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K | $1.00 K |
| Reserve & Surplus | $48.02 M | $87.79 M | $138.77 M | $161.25 M | $192.98 M | $268.10 M |
| Non-Current Liabilities | $159.89 M | $154.79 M | $149.69 M | $149.28 M | $144.13 M | $139.77 M |
| Current Liabilities | $175.12 M | $180.13 M | $223.40 M | $252.13 M | $217.34 M | $234.07 M |
| Total Liabilities | $335.01 M | $334.93 M | $373.10 M | $401.41 M | $361.48 M | $373.84 M |
| Fixed Assets | $108.68 M | $102.72 M | $96.82 M | $89.42 M | $83.46 M | $77.50 M |
| Current Assets | $642.69 M | $691.35 M | $838.80 M | $907.01 M | $778.82 M | $814.33 M |
| Total Assets | $1.06 B | $1.11 B | $1.21 B | $1.27 B | $1.27 B | $1.37 B |
Harmony Biosciences Holdings, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $45.56 M | $39.78 M | $50.87 M | $22.49 M | $32.49 M | $75.43 M |
| Operating Cash Flow | $33.99 M | $79.33 M | $108.73 M | $126.15 M | $27.76 M | $92.43 M |
| Investing Cash Flow | $2.36 M | -$19.59 M | -$4.79 M | -$17.63 M | -$183.65 M | -$131.50 M |
| Financing Cash Flow | -$352.00 K | -$2.69 M | -$3.00 M | -$3.02 M | -$7.22 M | -$558.00 K |
| Change in Cash | $36.00 M | $57.05 M | $100.95 M | $105.50 M | -$163.10 M | -$39.63 M |
Harmony Biosciences Holdings, Inc. Common Stock Return Calculator
The Harmony Biosciences Holdings, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$11,449
Invested Amount$10,000
Est. Returns$1,449
About Harmony Biosciences Holdings, Inc. Common Stock
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Popular Stocks
FAQs
What is the share price of Harmony Biosciences Holdings, Inc. Common Stock today?
Harmony Biosciences Holdings, Inc. Common Stock (HRMY) share price as of September 18, 2026 is $42.12. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Harmony Biosciences Holdings, Inc. Common Stock?
Yes, Indian Investors can invest in the Harmony Biosciences Holdings, Inc. Common Stock (HRMY) Share by opening an international trading account with Angel One.
How can I purchase Harmony Biosciences Holdings, Inc. Common Stock shares in India?
Purchasing Harmony Biosciences Holdings, Inc. Common Stock (HRMY) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Harmony Biosciences Holdings, Inc. Common Stock (HRMY) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Harmony Biosciences Holdings, Inc. Common Stock?
Yes, you can purchase fractional shares of Harmony Biosciences Holdings, Inc. Common Stock (HRMY) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Harmony Biosciences Holdings, Inc. Common Stock?
The market capitalization of Harmony Biosciences Holdings, Inc. Common Stock on September 18, 2026, is $2.46 B.
In which sector Harmony Biosciences Holdings, Inc. Common Stock belongs?
Harmony Biosciences Holdings, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Harmony Biosciences Holdings, Inc. Common Stock stocks?
In order to invest in Harmony Biosciences Holdings, Inc. Common Stock (HRMY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
